Page 3 - Polypid Ltd News Today

Gainers

Gainers

PETACH TIKVA, Israel, Sept. 22, 2023 (GLOBE NEWSWIRE) -- PolyPid Ltd. (NASDAQ:PYPD), ("PolyPid" or the "Company"), a late-stage biopharma company aiming to improve surgical outcomes, today announced that Company's

PETACH TIKVA, Israel, Sept. 21, 2023 -- PolyPid Ltd. , a late-stage biopharma company aiming to improve surgical outcomes, today announced that the Israeli Ministry of Health has completed a...

PETACH TIKVA, Israel, Sept. 21, 2023 (GLOBE NEWSWIRE) -- PolyPid Ltd. (NASDAQ:PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company aiming to improve surgical outcomes, today announced that the Israeli

Successful Audit of the Company’s State-of-the-Art Manufacturing Facility Represents a Key Milestone Toward Plan to Commercialize D-PLEX₁₀₀ Globally...

19.09.2023 - Company has Successfully Completed the Production of Three Process Validation Batches at Commercial Scale Completes a Substantial Requirement Toward the Planned Submission of D-PLEX100 NDA and MAA Regulatory Filings PETACH TIKVA, Israel, Sept. ... Seite 1

PolyPid Ltd. (NASDAQ:PYPD – Get Free Report) was the target of a significant decrease in short interest in the month of August. As of August 31st, there was short interest totalling 13,300 shares, a decrease of 81.3% from the August 15th total of 71,100 shares. Based on an average daily trading volume, of 66,000 shares, […]

PolyPid (NASDAQ:PYPD – Get Free Report) and Merit Medical Systems (NASDAQ:MMSI – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, profitability, institutional ownership and valuation. Profitability This table compares PolyPid and Merit Medical […]

Gainers